Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, September 13, 2016
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
[ Tue, Sep 13th 2016
] - WOPRAI
Christopher Raymond Initiated (VRTX) at Hold on, Sep 13th, 2016
Christopher Raymond of Raymond James, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold on, Sep 13th, 2016.
Christopher has made no other calls on VRTX in the last 4 months.
There is 1 other peer that has a rating on VRTX. Out of the 1 peers that are also analyzing VRTX, 0 agree with Christopher's Rating of Hold.
This is the rating of the analyst that currently disagrees with Christopher
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $139 on, Thursday, July 28th, 2016
Similar Stocks and Investing Articles
[ Wed, Aug 17th 2016
] - WOPRAI
[ Thu, Jul 28th 2016
] - WOPRAI
[ Mon, Jul 27th 2015
] - WOPRAI
[ Mon, Apr 22nd 2013
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Tue, May 08th 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Mon, Mar 19th 2012
] - WOPRAI